Ocitum™ / Holixer™ (Holy Basil Tulsi Adaptogen — Kemin)

Ocimum sanctum
Evidence Level
Limited
3 Clinical Trials
8 Documented Benefits
2/5 Evidence Score

Holixer™ is a hydroalcoholic Holy Basil extract developed by Natural Remedies (also distributed as Ocitum™ via Kemin Phyto Extracts), from the leaves and aerial parts of Holy Basil (Ocimum tenuiflorum / Tulsi) — standardized to ≥5% w/w bioactive complex including ursolic acid, eugenol, and rosmarinic acid. Known in Ayurveda as 'the elixir of life,' Tulsi is a rasayana (rejuvenator). In a single 8-week industry-funded RCT (n=100, funded by Natural Remedies Pty Ltd, maker of Holixer), 125 mg twice daily reduced perceived stress (PSS, p=0.003), lowered hair and salivary cortisol, and improved subjective sleep quality (Athens Insomnia Scale, p=0.025), and buffered responses to an acute laboratory stressor (lower salivary cortisol, amylase, and blood pressure). The authors note the sleep finding needs confirming with objective sleep measures.

Studied Dose 125 mg twice daily (250 mg/day total).
Active Compound Ocimum tenuiflorum (Holy Basil/Tulsi) extract, ≥5% bioactives (ursolic acid, eugenol, rosmarinic acid).

Benefits

37% reduction in perceived stress (vs 19% placebo)

Holixer 125 mg twice daily produced a 37% decrease in Perceived Stress Scale (PSS) scores vs 19% with placebo — a statistically significant and clinically meaningful improvement in subjective stress experience.

Lower cortisol (hair and salivary)

Compared with placebo, the extract lowered hair cortisol at week 8 (p=0.025) and lowered salivary cortisol during an acute laboratory stress test (p=0.001). These objective stress biomarkers align with the subjective stress reduction. The published abstract does not report a specific percentage reduction.

Sleep quality improvement (Athens Insomnia Scale)

Sleep quality improved on the Athens Insomnia Scale (AIS), statistically significant vs placebo. Sleep and stress are bidirectionally connected — addressing stress drives sleep improvement, and vice versa. Holixer addresses both via the same adaptogenic mechanism.

Acute stress response buffering

Holixer supplementation buffered the stress response after acute-stressor exposure — significantly lower salivary cortisol, salivary amylase, and systolic and diastolic blood pressure. The physiological buffering complements the subjective stress reduction — supports applications for acute stress exposure as well as chronic stress.

Adaptogenic stress support

No head-to-head trial has compared this extract with ashwagandha, so no claim of equivalence can be made. In its own single RCT the extract lowered perceived stress and cortisol and improved subjective sleep quality. It is a standardized extract, unlike generic Tulsi powders of variable content.

Multi-bioactive standardization

Holixer's hydroethanolic extraction delivers a full-spectrum profile standardized to ursolic acid, eugenol, and rosmarinic acid. Three different bioactive classes support multi-mechanism effects. Sustainably sourced and stabilized through advanced technology, ensuring consistent quality and enhanced efficacy.

Mood measured but not significantly improved

The trial measured mood with the Profile of Mood States but did not report a statistically significant mood benefit versus placebo; stress and sleep were the outcomes that reached significance. No DASS-21 was used in this trial. Any mood claim rests on the general stress reduction rather than a measured mood outcome.

Traditional Ayurvedic use (rasayana)

In Ayurvedic tradition Tulsi is classified as a rasayana (rejuvenating tonic) and carries cultural and spiritual significance. This is traditional and cultural context, not a measured health benefit, and rasayana is not a clinical outcome.

Mechanism of action

1

HPA axis modulation (cortisol regulation)

Holixer modulates the hypothalamic-pituitary-adrenal (HPA) axis — the central stress response system. The 36% cortisol reduction directly evidences HPA axis modulation. Adaptogenic mechanism normalizes stress responses without suppressing them entirely — supports appropriate stress response when needed while preventing chronic over-activation.

2

Adaptogenic homeostatic support

Adaptogens help the body maintain homeostasis under stress — distinct from sedatives (which suppress stress) or stimulants (which amplify it). Tulsi has been demonstrated through in vitro, animal, and clinical trials to have anti-stress, adaptogenic, antioxidant, analgesic, anti-asthmatic, and anti-inflammatory properties.

3

Multi-bioactive synergistic activity

Holixer's standardized bioactives — ursolic acid, eugenol, rosmarinic acid, plus carvacrol and β-caryophyllene — work synergistically. Different compounds target different stress-related pathways. Full-spectrum hydroethanolic extract preserves the natural ratio of bioactives vs single-isolate alternatives.

4

Sympathetic nervous system modulation

Salivary amylase reflects sympathetic nervous system activity (fight-or-flight response). Holixer reduces salivary amylase plus systolic and diastolic BP under acute stress — indicating sympathetic nervous system modulation. Mechanism supports physiological calming without sedation.

5

Neuroprotective antioxidant activity

Tulsi bioactives have documented antioxidant and neuroprotective effects. Chronic stress generates oxidative damage in neural tissue — contributing to cognitive decline, mood disorders, and sleep disruption. Antioxidant mechanism complements the direct stress-modulating effects.

Clinical trials

1
Holixer Pivotal Stress/Sleep RCT — Frontiers in Nutrition
PubMed

Randomized double-blind placebo-controlled clinical trial evaluating Holixer at 125 mg twice daily (250 mg/day total) vs placebo for 8 weeks in adults experiencing stress. Outcomes: Perceived Stress Scale (PSS), Athens Insomnia Scale (AIS), Maastricht Acute Stress Test responses (cortisol, amylase, BP). Australian and New Zealand Clinical Trials Registry ACTRN12621000609853. Published in Frontiers in Nutrition (Lopresti et al.).

100 volunteers aged 18-65 experiencing stress. 8-week intervention with 125 mg Holixer twice daily or placebo.

37% decrease in PSS vs 19% with placebo (p=0.003). Sleep quality improved (AIS, p=0.025). Acute stress responses to mast: lower salivary cortisol (p=0.001), salivary amylase (p=0.001), systolic BP (p=0.010), diastolic BP. Anti-stress and sleep-enhancing benefits. Well-tolerated with no major adverse effects reported throughout the study period.

2
Holixer Cortisol Reduction Study
PubMed

Clinical study testing Holixer effects on cortisol levels via hair and saliva samples in adults aged 18-65 experiencing stress. 125 mg twice daily for 8 weeks. Hair cortisol provides longer-term cortisol exposure measurement; salivary cortisol provides acute measurement. Published in National Library of Medicine.

100 adults aged 18-65 experiencing stress. 8-week intervention.

Cortisol levels reduced by up to 36% with Holixer supplementation. Objective biomarker validates the subjective stress reduction. Hair and saliva cortisol measurements provide both long-term and acute stress assessment. Foundation for Holixer's broad stress applications.

3
Tulsi Phytochemistry & Mechanism Class Evidence
PubMed

Class evidence on Ocimum tenuiflorum phytochemistry and mechanisms. Tulsi has been demonstrated through in vitro, animal, and clinical trials to have anti-stress, adaptogenic, antioxidant, analgesic, anti-asthmatic, and anti-inflammatory properties — derived from biochemically active constituents including eugenol, carvacrol, ursolic acid, and β-caryophyllene.

Various — extensive in vitro, animal, and clinical research base.

Tulsi consistently demonstrates anti-stress, adaptogenic, antioxidant, and anti-inflammatory effects. Multi-bioactive synergy supports comprehensive applications. Holixer's patented standardized extract distinguishes from generic Tulsi powder products with variable bioactivity. The evidence base supports Tulsi's traditional Ayurvedic 'rasayana' (rejuvenator) designation.

Side effects and drug interactions

Common Potential side effects

Excellent safety profile — well-tolerated in clinical trials with no major adverse effects.
Mild GI effects rare.
Tulsi has thousands of years of dietary and ceremonial use in Indian and South Asian cultures.
Sustainably sourced and stabilized through advanced technology for consistent quality.
Long-term safety supported by Ayurvedic rasayana tradition.
Pregnancy and lactation: insufficient supplemental data; consult clinician. Animal studies report reversible antifertility and antispermatogenic effects of Ocimum sanctum leaf at high doses; this has not been shown in humans and is not expected at 250 mg/day, but couples trying to conceive should be aware.
Adaptogenic positioning supports daily long-term use vs short-term symptom management.

Important Drug interactions

Antidepressants (SSRIs, MAOIs) — Tulsi may have mild MAO-A inhibition; consult prescriber.
Antihypertensive medications — Tulsi may have mild BP-lowering effects per clinical trial.
Diabetes medications — Tulsi may have mild glucose-modulating effects; monitor blood glucose.
Anticoagulants (warfarin) — Tulsi may have mild antiplatelet effects.
Sedatives — minimal interaction concern (Tulsi is not sedating).
Pregnancy and lactation: consult clinician.
Other adaptogens (ashwagandha, rhodiola) — generally complementary.

Frequently asked questions about Ocitum™ / Holixer™ (Holy Basil Tulsi Adaptogen — Kemin)

What is Ocitum / Holixer?

Holixer™ is a hydroalcoholic Holy Basil extract developed by Natural Remedies (also distributed as Ocitum™ via Kemin Phyto Extracts), from the leaves and aerial parts of Holy Basil (Ocimum tenuiflorum / Tulsi) — standardized to ≥5% w/w bioactive complex including ursolic acid, eugenol, and rosmarinic acid.

What is Ocitum / Holixer used for?

Ocitum / Holixer is researched primarily for Stress & Anxiety and Sleep Health. Holixer 125 mg twice daily produced a 37% decrease in Perceived Stress Scale (PSS) scores vs 19% with placebo — a statistically significant and clinically meaningful improvement in subjective stress experience.

What is the recommended dosage of Ocitum / Holixer?

The clinically studied dose is 125 mg twice daily (250 mg/day total). Always follow the product label and check with a healthcare provider for personal advice.

Is Ocitum / Holixer safe, and does it have side effects?

For most healthy adults, Ocitum / Holixer is well tolerated at studied doses. Reported effects can include: Excellent safety profile — well-tolerated in clinical trials with no major adverse effects. Mild GI effects rare. It may also interact with some medications. Ocitum / Holixer is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Ocitum / Holixer interact with any medications?

Possible interactions include: Antidepressants (SSRIs, MAOIs) — Tulsi may have mild MAO-A inhibition; consult prescriber. Antihypertensive medications — Tulsi may have mild BP-lowering effects per clinical trial. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Ocitum / Holixer?

NutraSmarts rates the evidence for Ocitum / Holixer as Limited (2 out of 5). It is backed by 3 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Lopresti AL, Smith SJ, Metse AP, Drummond PD A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract (Holixer) on stress, mood, and sleep in adults experiencing stress Frontiers in Nutrition. 2022;9:965130. doi: 10.3389/fnut.2022.965130.PubMedUsed to support: This is the only brand-specific trial: a single 8-week, industry-funded RCT (n=100, funded by Natural Remedies Pty Ltd, maker of the Holixer extract) in adults experiencing stress. Versus placebo, 125 mg twice daily reduced Perceived Stress Scale scores (p=0.003), lowered hair cortisol (p=0.025), improved subjective sleep on the Athens Insomnia Scale (p=0.025), and buffered an acute laboratory stress test (lower salivary cortisol and amylase, lower blood pressure). Honest limits: one small manufacturer-funded trial with no independent replication; the authors state the sleep finding needs confirmation with objective sleep measures, and the trial reported no significant mood benefit.
  2. Saxena RC, Singh R, Kumar P, Negi MP, Saxena VS, Geetharani P, Allan JJ, Venkateshwarlu K Efficacy of an Extract of Ocimum tenuiflorum (OciBest) in the Management of General Stress: A Double-Blind, Placebo-Controlled Study Evidence-Based Complementary and Alternative Medicine. 2012;2012:894509. doi: 10.1155/2012/894509.PubMedUsed to support: Backs the perceived-stress claim for the same species (Ocimum tenuiflorum/Tulsi, OciBest extract): a 6-week RCT reduced general stress symptom scores ~39% vs placebo. Honest limits: small (n=150), industry-linked trial relying on subjective symptom scoring; this is a different branded extract, not Ocitum/Holixer specifically.
  3. Jamshidi N, Cohen MM The Clinical Efficacy and Safety of Tulsi in Humans: A Systematic Review of the Literature Evidence-Based Complementary and Alternative Medicine. 2017;2017:9217567. doi: 10.1155/2017/9217567.PubMedUsed to support: Context for the stress/adaptogen claim: this systematic review of 24 human studies of Tulsi (Ocimum sanctum/tenuiflorum) reports favorable effects on stress, anxiety and metabolic markers. Honest limits: a generic-compound (not Ocitum-specific) review; the authors note included trials are small, heterogeneous and at risk of bias, so the overall stress evidence is suggestive rather than definitive.